Cargando…
PB2183: TRANSFUSION-RELATED COST OFFSETS AND TIME BURDEN IN PATIENTS WITH MYELOFIBROSIS (MF) TREATED WITH MOMELOTINIB (MMB) VS DANAZOL (DAN)
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428794/ http://dx.doi.org/10.1097/01.HS9.0000975484.93174.12 |
_version_ | 1785090555262271488 |
---|---|
author | Masarova, Lucia Verstovsek, Srdan Liu, Tom Rao, Sumati Sajeev, Guatam Simpson, Ryan LI, Weilong Yang, Joseph Gorsh, Boris Signorovitch, James |
author_facet | Masarova, Lucia Verstovsek, Srdan Liu, Tom Rao, Sumati Sajeev, Guatam Simpson, Ryan LI, Weilong Yang, Joseph Gorsh, Boris Signorovitch, James |
author_sort | Masarova, Lucia |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10428794 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104287942023-08-17 PB2183: TRANSFUSION-RELATED COST OFFSETS AND TIME BURDEN IN PATIENTS WITH MYELOFIBROSIS (MF) TREATED WITH MOMELOTINIB (MMB) VS DANAZOL (DAN) Masarova, Lucia Verstovsek, Srdan Liu, Tom Rao, Sumati Sajeev, Guatam Simpson, Ryan LI, Weilong Yang, Joseph Gorsh, Boris Signorovitch, James Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428794/ http://dx.doi.org/10.1097/01.HS9.0000975484.93174.12 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Publication Only Masarova, Lucia Verstovsek, Srdan Liu, Tom Rao, Sumati Sajeev, Guatam Simpson, Ryan LI, Weilong Yang, Joseph Gorsh, Boris Signorovitch, James PB2183: TRANSFUSION-RELATED COST OFFSETS AND TIME BURDEN IN PATIENTS WITH MYELOFIBROSIS (MF) TREATED WITH MOMELOTINIB (MMB) VS DANAZOL (DAN) |
title | PB2183: TRANSFUSION-RELATED COST OFFSETS AND TIME BURDEN IN PATIENTS WITH MYELOFIBROSIS (MF) TREATED WITH MOMELOTINIB (MMB) VS DANAZOL (DAN) |
title_full | PB2183: TRANSFUSION-RELATED COST OFFSETS AND TIME BURDEN IN PATIENTS WITH MYELOFIBROSIS (MF) TREATED WITH MOMELOTINIB (MMB) VS DANAZOL (DAN) |
title_fullStr | PB2183: TRANSFUSION-RELATED COST OFFSETS AND TIME BURDEN IN PATIENTS WITH MYELOFIBROSIS (MF) TREATED WITH MOMELOTINIB (MMB) VS DANAZOL (DAN) |
title_full_unstemmed | PB2183: TRANSFUSION-RELATED COST OFFSETS AND TIME BURDEN IN PATIENTS WITH MYELOFIBROSIS (MF) TREATED WITH MOMELOTINIB (MMB) VS DANAZOL (DAN) |
title_short | PB2183: TRANSFUSION-RELATED COST OFFSETS AND TIME BURDEN IN PATIENTS WITH MYELOFIBROSIS (MF) TREATED WITH MOMELOTINIB (MMB) VS DANAZOL (DAN) |
title_sort | pb2183: transfusion-related cost offsets and time burden in patients with myelofibrosis (mf) treated with momelotinib (mmb) vs danazol (dan) |
topic | Publication Only |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428794/ http://dx.doi.org/10.1097/01.HS9.0000975484.93174.12 |
work_keys_str_mv | AT masarovalucia pb2183transfusionrelatedcostoffsetsandtimeburdeninpatientswithmyelofibrosismftreatedwithmomelotinibmmbvsdanazoldan AT verstovseksrdan pb2183transfusionrelatedcostoffsetsandtimeburdeninpatientswithmyelofibrosismftreatedwithmomelotinibmmbvsdanazoldan AT liutom pb2183transfusionrelatedcostoffsetsandtimeburdeninpatientswithmyelofibrosismftreatedwithmomelotinibmmbvsdanazoldan AT raosumati pb2183transfusionrelatedcostoffsetsandtimeburdeninpatientswithmyelofibrosismftreatedwithmomelotinibmmbvsdanazoldan AT sajeevguatam pb2183transfusionrelatedcostoffsetsandtimeburdeninpatientswithmyelofibrosismftreatedwithmomelotinibmmbvsdanazoldan AT simpsonryan pb2183transfusionrelatedcostoffsetsandtimeburdeninpatientswithmyelofibrosismftreatedwithmomelotinibmmbvsdanazoldan AT liweilong pb2183transfusionrelatedcostoffsetsandtimeburdeninpatientswithmyelofibrosismftreatedwithmomelotinibmmbvsdanazoldan AT yangjoseph pb2183transfusionrelatedcostoffsetsandtimeburdeninpatientswithmyelofibrosismftreatedwithmomelotinibmmbvsdanazoldan AT gorshboris pb2183transfusionrelatedcostoffsetsandtimeburdeninpatientswithmyelofibrosismftreatedwithmomelotinibmmbvsdanazoldan AT signorovitchjames pb2183transfusionrelatedcostoffsetsandtimeburdeninpatientswithmyelofibrosismftreatedwithmomelotinibmmbvsdanazoldan |